Katherine Floyd1, Andrea Pantoja. 1. Stop TB Department, World Health Organization, Geneva, Switzerland. floydk@who.int
Abstract
OBJECTIVE: To estimate the financial resources required to achieve the 2015 targets for global tuberculosis (TB) control, which have been set within the framework of the Millennium Development Goals (MDGs). METHODS: The Global Plan to Stop TB, 2006-2015 was developed by the Stop TB Partnership. It sets out what needs to be done to achieve the 2015 targets for global TB control, based on WHO's Stop TB Strategy. Plan costs were estimated using spreadsheet models that included epidemiological, demographic, planning and unit cost data. FINDINGS: A total of US$ 56 billion is required during the period 2006-2015 (93% for TB-endemic countries, 7% for international technical agencies), increasing from US$ 3.5 billion in 2006 to US$ 6.7 billion in 2015. The single biggest cost (US$ 3 billion per year) is for the treatment of drug-susceptible cases in DOTS programmes. Other major costs are treatment of patients with multi- and extensively drug-resistant TB (MDR-TB and XDR-TB), collaborative TB/HIV activities, and advocacy, communication and social mobilization. Low-income countries account for 41% of total funding needs and 65% of funding needs for TB/HIV. Middle-income countries account for 72% of the funding needed for treatment of MDR-TB and XDR-TB. African countries require the largest increases in funding. CONCLUSION: Achieving the 2015 global targets set for TB control requires a major increase in funding. To support resource mobilization, comprehensive and costed national plans that are in line with the Global Plan to Stop TB are needed, backed up by robust assessments of the funding that can be raised in each country from domestic sources and the balance that is needed from donors.
OBJECTIVE: To estimate the financial resources required to achieve the 2015 targets for global tuberculosis (TB) control, which have been set within the framework of the Millennium Development Goals (MDGs). METHODS: The Global Plan to Stop TB, 2006-2015 was developed by the Stop TB Partnership. It sets out what needs to be done to achieve the 2015 targets for global TB control, based on WHO's Stop TB Strategy. Plan costs were estimated using spreadsheet models that included epidemiological, demographic, planning and unit cost data. FINDINGS: A total of US$ 56 billion is required during the period 2006-2015 (93% for TB-endemic countries, 7% for international technical agencies), increasing from US$ 3.5 billion in 2006 to US$ 6.7 billion in 2015. The single biggest cost (US$ 3 billion per year) is for the treatment of drug-susceptible cases in DOTS programmes. Other major costs are treatment of patients with multi- and extensively drug-resistant TB (MDR-TB and XDR-TB), collaborative TB/HIV activities, and advocacy, communication and social mobilization. Low-income countries account for 41% of total funding needs and 65% of funding needs for TB/HIV. Middle-income countries account for 72% of the funding needed for treatment of MDR-TB and XDR-TB. African countries require the largest increases in funding. CONCLUSION: Achieving the 2015 global targets set for TB control requires a major increase in funding. To support resource mobilization, comprehensive and costed national plans that are in line with the Global Plan to Stop TB are needed, backed up by robust assessments of the funding that can be raised in each country from domestic sources and the balance that is needed from donors.
Authors: Harry Peter Hausler; Edina Sinanovic; Lilani Kumaranayake; Pren Naidoo; Hennie Schoeman; Barbara Karpakis; Peter Godfrey-Faussett Journal: Bull World Health Organ Date: 2006-07 Impact factor: 9.408
Authors: Dermot Maher; Chris Dye; Katherine Floyd; Andrea Pantoja; Knut Lonnroth; Alasdair Reid; Eva Nathanson; Thad Pennas; Uli Fruth; Jane Cunningham; Heather Ignatius; Mario C Raviglione; Irene Koek; Marcos Espinal Journal: Bull World Health Organ Date: 2007-05 Impact factor: 9.408
Authors: Karin Stenberg; Benjamin Johns; Robert W Scherpbier; Tessa Tan-Torres Edejer Journal: Bull World Health Organ Date: 2007-04 Impact factor: 9.408
Authors: Eline L Korenromp; Philippe Glaziou; Christopher Fitzpatrick; Katherine Floyd; Mehran Hosseini; Mario Raviglione; Rifat Atun; Brian Williams Journal: PLoS One Date: 2012-06-18 Impact factor: 3.240
Authors: G Suzanne A Smit; Ludwig Apers; Wouter Arrazola de Onate; Philippe Beutels; Pierre Dorny; An-Marie Forier; Kristien Janssens; Jean Macq; Ruud Mak; Sandrina Schol; Dirk Wildemeersch; Niko Speybroeck; Brecht Devleesschauwer Journal: Bull World Health Organ Date: 2016-11-03 Impact factor: 9.408
Authors: Tom Wingfield; Marco A Tovar; Doug Huff; Delia Boccia; Rosario Montoya; Eric Ramos; Sumona Datta; Matthew J Saunders; James J Lewis; Robert H Gilman; Carlton A Evans Journal: Bull World Health Organ Date: 2017-02-09 Impact factor: 9.408
Authors: Tom Wingfield; Delia Boccia; Marco A Tovar; Doug Huff; Rosario Montoya; James J Lewis; Robert H Gilman; Carlton A Evans Journal: BMC Public Health Date: 2015-08-21 Impact factor: 3.295
Authors: R S Garfein; K Collins; F Muñoz; K Moser; P Cerecer-Callu; F Raab; P Rios; A Flick; M L Zúñiga; J Cuevas-Mota; K Liang; G Rangel; J L Burgos; T C Rodwell; K Patrick Journal: Int J Tuberc Lung Dis Date: 2015-09 Impact factor: 2.373